Early research (Phase 1)Study completedNCT01219348What this trial is testingIDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.Who this might be right forNSCLCLung Cancer Inge Marie Svane 14
Not applicableStudy completedNCT05796726What this trial is testingRetrospective Chart Review and Historical Comparison of Capmatinib vs. Standard of Care for German Adult Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring METex14 MutationsWho this might be right forLocally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations Novartis Pharmaceuticals 260
Large-scale testing (Phase 3)Looking for participantsNCT07668752What this trial is testingEvaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D MutationWho this might be right forKRAS G12D MutationNSCLC (Non-small Cell Lung Cancer) Genfleet Therapeutics (Shanghai) Inc. 300
Testing effectiveness (Phase 2)Study completedNCT05269485What this trial is testingHypofraction Radiotherapy for Locally Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung CancerRadiotherapy Side Effect Anhui Provincial Hospital 36
Early research (Phase 1)Study completedNCT04360915What this trial is testingAssessing the Pharmacokinetics Effects of Food on ASK120067 in Single Oral Administration in Chinese Healthy SubjectsWho this might be right forLocally Advanced or Metastatic NSCLC Jiangsu Aosaikang Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06606847What this trial is testingInvestigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)Who this might be right forNon-Small Cell Lung Cancer AstraZeneca 30
Large-scale testing (Phase 3)UnknownNCT04239833What this trial is testingSH-1028 Tablets Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Nanjing Sanhome Pharmaceutical, Co., Ltd. 240
Testing effectiveness (Phase 2)Looking for participantsNCT07224152What this trial is testingNBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung CancerWho this might be right forLocally-Advanced Non-Small Cell Lung Cancer M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Active Not RecruitingNCT07183189What this trial is testingSHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLCWho this might be right forNon-small Cell Lung Cancer Suzhou Suncadia Biopharmaceuticals Co., Ltd. 582
Not applicableLooking for participantsNCT07164885What this trial is testingRAPART in Locally Advanced Non-small Cell Lung Cancer PatientsWho this might be right forLocally Advanced Non-small Cell Lung Cancer Capital Medical University 911
Testing effectiveness (Phase 2)Study completedNCT04905316What this trial is testingCanakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung CancerWho this might be right forNon-small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 41
Early research (Phase 1)Study completedNCT01325558What this trial is testingALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Malignant NeoplasmMalignant Solid Tumour Altor BioScience 30
Large-scale testing (Phase 3)WithdrawnNCT03529084What this trial is testingPhase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating MutationsWho this might be right forCarcinoma, Non-small Cell Lung Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05255406What this trial is testingEfficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE)Who this might be right forNon-Small-Cell Lung Cancer Fudan University 62
Large-scale testing (Phase 3)Looking for participantsNCT06417814What this trial is testingInvestigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forMetastatic Non-small Cell Lung Cancer AstraZeneca 744
Testing effectiveness (Phase 2)Study completedNCT00096226What this trial is testingPaclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerWho this might be right forLung Cancer Radiation Therapy Oncology Group 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04923906What this trial is testingAumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR MutationsWho this might be right forNon-small Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 624
Large-scale testing (Phase 3)Looking for participantsNCT07150663What this trial is testingNanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Changchun GeneScience Pharmaceutical Co., Ltd. 134
Large-scale testing (Phase 3)Looking for participantsNCT06545747What this trial is testingAdaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRIWho this might be right forNon-small Cell Lung Cancer Sun Yat-sen University 490
Testing effectiveness (Phase 2)Looking for participantsNCT06010329What this trial is testingEvaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLCWho this might be right forNon-small Cell Lung Cancer Teligene US 66